179 related articles for article (PubMed ID: 35440193)
1. [Chemotherapy and Radio-Chemotherapy of Locally Advanced Esophageal Cancer].
Wille K; Mann C; Berlth F; Fetzner UK; Othmann K; Mönig SP
Ther Umsch; 2022 Apr; 79(3-4):189-194. PubMed ID: 35440193
[TBL] [Abstract][Full Text] [Related]
2. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Porschen R; Fischbach W; Gockel I; Hollerbach S; Hölscher A; Jansen PL; Miehlke S; Pech O; Stahl M; Vanhoefer U; Ebert MPA
United European Gastroenterol J; 2024 Apr; 12(3):399-411. PubMed ID: 38284661
[TBL] [Abstract][Full Text] [Related]
3. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.
Cao XF; He XT; Ji L; Xiao J; Lv J
Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071
[TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
6. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Kersting S; Konopke R; Dittert D; Distler M; Rückert F; Gastmeier J; Baretton GB; Saeger HD
J Gastroenterol Hepatol; 2009 May; 24(5):886-95. PubMed ID: 19655439
[TBL] [Abstract][Full Text] [Related]
7. The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer.
Zacherl J
Dig Dis; 2014; 32(1-2):171-5. PubMed ID: 24603404
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
9. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
Lorenzen S; Biederstädt A; Ronellenfitsch U; Reißfelder C; Mönig S; Wenz F; Pauligk C; Walker M; Al-Batran SE; Haller B; Hofheinz RD
BMC Cancer; 2020 Sep; 20(1):886. PubMed ID: 32933498
[TBL] [Abstract][Full Text] [Related]
10. [Squamous cell carcinoma of the oesophagus--impact of surgery within the therapeutic concept].
Gockel I; Lang H
Z Gastroenterol; 2010 May; 48(5):560-6. PubMed ID: 20449788
[TBL] [Abstract][Full Text] [Related]
11. Esophageal Cancer: New Insights into a Heterogenous Disease.
Krug S; Michl P
Digestion; 2017; 95(4):253-261. PubMed ID: 28384630
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Therapies for Esophageal Cancer.
Abdelhakeem A; Blum Murphy M
Thorac Surg Clin; 2022 Nov; 32(4):457-465. PubMed ID: 36266033
[TBL] [Abstract][Full Text] [Related]
13. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction.
Samel S; Hofheinz R; Hundt A; Sturm J; Knoll MR; Wenz F; Queisser W; Post S
Onkologie; 2001 Jun; 24(3):278-82. PubMed ID: 11455222
[TBL] [Abstract][Full Text] [Related]
15. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
17. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
18. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.
Ancona E; Ruol A; Castoro C; Chiarion-Sileni V; Merigliano S; Santi S; Bonavina L; Peracchia A
Ann Surg; 1997 Dec; 226(6):714-23; discussion 723-4. PubMed ID: 9409570
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic analysis of different comprehensive treatment models for locally advanced esophageal squamous cell carcinoma based on propensity score matching].
Wang YC; Liu JF; Lu H; Zhang XR; Sun XS
Zhonghua Wai Ke Za Zhi; 2022 Jan; 60(1):79-83. PubMed ID: 34954951
[No Abstract] [Full Text] [Related]
20. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
Veuillez V; Rougier P; Seitz JF
Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]